Medical Devices

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.

At ECR 2026, Subtle Medical showcases AI that boosts existing scanners, expands into CT, and promises faster, clearer diagnostics for patients.

Greenwich LifeSciences' Phase III trial for its GLSI-100 immunotherapy is enrolling patients faster than ever, with early data echoing past success.

A €21.5M consortium is launching clinical trials for AI that assists in brain and cancer surgery, aiming to ease a critical European doctor shortage.

A novel CRISPR-based therapy safely targets deadly E. coli in the gut, showing promise in the fight against antibiotic resistance and for protecting cancer patients.

A 2.5-year-old's sudden paralysis led to a high-risk, pioneering neuro-intervention that reversed a severe stroke, setting a new benchmark for pediatric care.

With soaring revenue and new EU approval, Senseonics is taking control of its sales, but rising costs raise questions about its path to profitability.

Entrepreneur Daniel Gestetner discusses resilience, a $1B exit, and why true success isn't about winning at all costs in a revealing new podcast.

Peli BioThermal and Polar Group partner to upgrade Brazil's pharma logistics, tackling a booming market and ensuring safer delivery of advanced medicines.

Popular weight-loss drugs are linked to fewer ER visits for chronic migraine, a new study finds, sparking hope and questions about a new treatment frontier.

A new national agreement gives thousands of U.S. hospitals streamlined access to Nanosonics' trophon3, aiming to elevate patient safety standards.

From a viral sensation to a retail powerhouse, shapewear brand Popilush marks four years of innovation, award-winning design, and rapid expansion.

A new study aims to confirm a novel immunotherapy's dramatic results in colorectal cancer, offering hope for patients with limited treatment options.

With 14% growth, strategic acquisitions, and major AI advancements, Real Chemistry is redefining healthcare commercialization on its 25th anniversary.

The biopharma company's strategic bid for non-dilutive funding could advance a first-in-class therapy for severe, untreated skin conditions.

A new partnership brings advanced, non-invasive Alzheimer's blood tests to community centers, aiming for mass early detection and reshaping diagnostics.

Lantheus gains FDA tentative approval for a LUTATHERA rival, signaling new hope for rare cancer patients and a legal battle with Novartis over market access.

Regulatory delays in China scuttled Pulmatrix's merger with Cullgen, forcing the biotech to urgently seek new partners for its promising drug pipeline.

On its 13th anniversary, MOCO Connectors launched a new 8,000sqm facility in Zhongshan, scaling up custom connector production for global high-tech markets.

As AI reshapes medicine, Seoul prepares to host global experts to explore its vast potential and critical challenges in healthcare and medical tourism.